In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

Commentary Published: September 2000 Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Tomas Hanke & Andrew J. McMichael Nature Medicine 6, 951 ...

Learn how personalised cancer vaccines are revolutionising cancer treatment and how regulatory bodies like the FDA juggle trade-offs to ensure safe and effective treatments.

Here, we describe the epidemiology of RSV, the RSV virion structure, key neutralizing epitopes on the pre- and post-fusion forms of the fusion protein and implications for vaccine development.

PORTLAND, IN, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, “Cell Culture Media Market by Type (Natural Media, Artificial Media), by Application ...

Renowned virologist, Dr Simeon Agwale, has hinted that Lassa fever vaccine produced by a Nigerian has scaled through preclinical trials involving mice and ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insi ...

The strong antibody responses generated by vaccines provide an important first round of defense, but "you always want to have a backup plan," says Biomedical Graduate Studies Ph.D. student Emily A ...

Citing COVID-19 vaccine recommendations from other high-income countries — none of which has a universal recommendation — along with what they described as uncertainty about whether healthy ...